Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 36,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
Reporting to the VP, Market Access, Managed Markets, and Reimbursement, the Director has in-depth expertise in developing and implementing strategic and tactical pricing operations in the United States. The role is focused on driving the high level U.S. Pricing Strategy and execution via Pricing Committee while supporting internal and external customer focus in all aspects of the pricing process to help patients get access to HF10 therapy. In addition to driving data based decisions to drive continued revenue growth and profitability, a key aspect of this position is to collaborate with teammates on the Market Access team, Sales Leadership, the broader organization, as well as U.S. facility customers (Hospitals & ASCs). The candidate is highly analytical and skilled at developing relationships as well as working across the organization to achieve Market Access goals that are aligned with sales and marketing strategies.